CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE

摘要

Human CSNK1G genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of CSNK1G are provided.